Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis

被引:51
|
作者
Sardar, Rahila [1 ,2 ]
Satish, Deepshikha [1 ]
Gupta, Dinesh [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol ICGEB, Translat Bioinformat Grp, New Delhi, India
[2] Jamia Hamdard, Dept Biochem, New Delhi, India
关键词
regulatory network; miRNA; SARS-CoV-2; hub genes; TFS; VIRUS; EXPRESSION; INFECTION; MODULATION; RESOURCE; DATABASE; ALTERS;
D O I
10.3389/fgene.2020.571274
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Understanding the host regulatory mechanisms opposing virus infection and virulence can provide actionable insights to identify novel therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have used a network biology approach to elucidate the crucial factors involved in host responses involving host-microRNA (miRNA) interactions with host and virus genes using recently published experimentally verified protein-protein interaction data. We were able to identify 311 host genes to be potentially targetable by 2,197 human miRNAs. These miRNAs are known to be involved in various biological processes, such as T-cell differentiation and activation, virus replication, and immune system. Among these, the anti-viral activity of 38 miRNAs to target 148 host genes is experimentally validated. Six anti-viral miRNAs, namely, hsa-miR-1-3p, hsa-miR-17-5p, hsa-miR-199a-3p, hsa-miR-429, hsa-miR-15a-5p, and hsa-miR-20a-5p, are previously reported to be anti-viral in respiratory diseases and were found to be downregulated. The interaction network of the 2,197 human miRNAs and interacting transcription factors (TFs) enabled the identification of 51 miRNAs to interact with 77 TFs inducing activation or repression and affecting gene expression of linked genes. Further, from the gene regulatory network analysis, the top five hub genes HMOX1, DNMT1, PLAT, GDF1, and ITGB1 are found to be involved in interferon (IFN)-alpha 2b induction, epigenetic modification, and modulation of anti-viral activity. The comparative miRNAs target identification analysis in other respiratory viruses revealed the presence of 98 unique host miRNAs targeting SARS-CoV-2 genome. Our findings identify prioritized key regulatory interactions that include miRNAs and TFs that provide opportunities for the identification of novel drug targets and development of anti-viral drugs.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Publisher Correction: A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing
    Mahnaz Habibi
    Golnaz Taheri
    Rosa Aghdam
    Scientific Reports, 11
  • [42] Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis
    Mukhopadhyay, Debasmita
    Mussa, Bashair M.
    BRAIN SCIENCES, 2020, 10 (10) : 1 - 11
  • [43] Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2
    Sova, Milan
    Kudelka, Milos
    Raska, Milan
    Mizera, Jan
    Mikulkova, Zuzana
    Trajerova, Marketa
    Ochodkova, Eliska
    Genzor, Samuel
    Jakubec, Petr
    Borikova, Alena
    Stepanek, Ladislav
    Kosztyu, Petr
    Kriegova, Eva
    VIRUSES-BASEL, 2022, 14 (11):
  • [44] Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing
    Raj, Resal
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 25
  • [45] Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach
    Yasmin, Sabina
    Ansari, Mohammad Yousuf
    Pandey, Krishna
    Dikhit, Manas Ranjan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 265
  • [46] Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19
    Bhavaniramya, Sundaresan
    Ramar, Vanajothi
    Vishnupriya, Selvaraju
    Palaniappan, Ramasamy
    Sibiya, Ashokkumar
    Vaseeharan, Baskaralingam
    CURRENT MOLECULAR PHARMACOLOGY, 2022, 15 (02) : 393 - 417
  • [47] Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets
    Oliveira, Sergio C.
    de Magalhaes, Mariana T. Q.
    Homan, E. Jane
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [48] Molecular Docking in silico Analysis of Brazilian Essential Oils Against Host Targets and SARS-CoV-2 Proteins
    Costa, Remullo B. G. M.
    Martins, Regildo M. G.
    de Lima, Gerlane S.
    Stamford, Thayza C. M.
    Tadei, Wanderli P.
    Maciel, Maria Aparecida M.
    do Rego, Amalia C. M.
    Xavier-Junior, Francisco H.
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2022, 33 (10) : 1219 - 1235
  • [49] Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity, and possible drug therapeutics
    Parvez, Md Sorwer Alam
    Saha, Manash Kumar
    Ibrahim, Md
    Araf, Yusha
    Islam, Md Taufiqul
    Ohtsuki, Gen
    Hosen, Mohammad Jakir
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (07)
  • [50] Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome
    Fang, Jiansong
    Wu, Qihui
    Ye, Fei
    Cai, Chuipu
    Xu, Lvjie
    Gu, Yong
    Wang, Qi
    Liu, Ai-lin
    Tan, Wenjie
    Du, Guan-hua
    FRONTIERS IN GENETICS, 2021, 12